Description

The high prevalence of diseases in Europe is a market opportunities for the market participants, especially considering the ageing population in these regions. This leads to the need for better and early diagnosis. This market includes revenues from instruments and reagents. Market revenues and installed base (units) for the entire Western Europe, the United Kingdom, France, Germany, Italy, Spain, Nordic countries, and Benelux have been included in this study.